Clinical Trials

NCT05835037 | RECRUITING | PHASE4
200 participants

Effect of Zinc on Glucose Homeostasis

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2024-02-16
Completion:
2028-07-31
Conditions
  • Prediabetic State
  • Hyperglycemia
Interventions
  • DRUG
No Results Yet
NCT05787821 | ACTIVE_NOT_RECRUITING
760 participants

Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-10
Start Date:
2023-06-28
Completion:
2026-06-30
Conditions
  • Knee Pain Chronic
  • Osteoarthritis, Knee
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Polyarthritis
  • Varus Deformity
  • Valgus Deformity
  • Flexion Deformity of Knee
  • Avascular Necrosis
Interventions
  • DEVICE
No Results Yet
NCT05726864 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
158 participants

A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2023-04-14
Completion:
2026-04-20
Conditions
  • Pancreatic Ductal Adenocarcinoma
  • Colorectal Cancer
  • KRAS G12D
  • KRAS G12R
  • KRAS G12V
  • KRAS G12A
  • KRAS G12C
  • KRAS G12S
  • KRAS G13D
  • NRAS G12D
  • NRAS G12R
  • NRAS G12V
  • NRAS G12C
  • NRAS G12S
Interventions
  • DRUG
No Results Yet
NCT05721755 | ACTIVE_NOT_RECRUITING | PHASE3
290 participants

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2023-06-08
Completion:
2029-03-31
Conditions
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Hypopharyngeal Squamous Cell Carcinoma
  • Metastatic Laryngeal Squamous Cell Carcinoma
  • Metastatic Oral Cavity Squamous Cell Carcinoma
  • Metastatic Oropharyngeal Squamous Cell Carcinoma
  • Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
  • Stage IV Hypopharyngeal Carcinoma AJCC v8
  • Stage IV Laryngeal Cancer AJCC v8
  • Stage IV Lip and Oral Cavity Cancer AJCC v8
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
  • RADIATION
No Results Yet
NCT05672251 | RECRUITING | PHASE2
36 participants

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2024-01-02
Completion:
2027-03-23
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Grade 3b Follicular Lymphoma
  • Recurrent High Grade B-Cell Lymphoma
  • Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • Recurrent Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Grade 3b Follicular Lymphoma
  • Refractory High Grade B-Cell Lymphoma
  • Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • Refractory Transformed Chronic Lymphocytic Leukemia
  • Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT05534438 | RECRUITING | PHASE2
46 participants

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2022-09-06
Completion:
2026-09-06
Conditions
  • Oligometastatic Breast Carcinoma
  • Breast Cancer
  • Metastatic Breast Cancer
  • Metastatic Breast Carcinoma
  • ER+ Breast Cancer
  • HER2+ Breast Cancer
Interventions
  • RADIATION
No Results Yet
NCT05503264 | ACTIVE_NOT_RECRUITING | PHASE3
122 participants

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2022-09-27
Completion:
2026-12-16
Conditions
  • NMDAR Autoimmune Encephalitis
  • LGI1 Autoimmune Encephalitis
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT05458674 | ACTIVE_NOT_RECRUITING | PHASE2
17 participants

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-10
Start Date:
2024-01-30
Completion:
2027-06-01
Conditions
  • Breast Cancer
  • Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page